N-(2-HYDROXY-6-NITROPHENYL)BUTYRAMIDE, 95.0%, 500mg

2-((2R,3R)-3-(tert-Butyl)-4-(2,6-dimethoxyphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphol-2-yl)-6-methoxypyridine, 97%, 100mg

1-(2-Deoxy-2-fluoro-b-D-arabinofuranosyl)uracil, 95.0%, 10g

ROTIPHORESE®Gel A, 1 l

4-(3-aminopropyl)-1,3-thiazol-2-amine dihydrochloride, 95.0%, 25g

1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oic acid, 98%, 250mg

3-methoxy-N-[(piperidin-4-yl)methyl]pyridin-2-amine trihydrochloride, 1g

5-(4-piperidinyl)-4H-1,2,4-triazol-3-amine dihydrochloride, 95.0%, 1g

(4-Methylpyrimidin-2-yl)methanol, 95.0%, 100mg

3,4-Dimethoxycyclobut-3-ene-1,2-dione, 98.00%, 1g

2-(1-pyrrolidinylmethyl)-1,4-oxazepane, 95.0%, 1g

2-p-Tolyl-ethanesulfonyl chloride, 1g

2-Methyl-2-phenylpropanenitrile>98.0%(GC)1g